MedPath

AUSTIN SPEECH LABS, INC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

tDCS as an Adjuvant to Intensive Speech Therapy for Chronic Post Stroke Aphasia

Not Applicable
Conditions
Aphasia
Language
First Posted Date
2016-06-16
Last Posted Date
2017-07-02
Lead Sponsor
Austin Speech Labs
Target Recruit Count
6
Registration Number
NCT02801864
Locations
🇺🇸

Austin Speech Labs, Austin, Texas, United States

Phonological Treatment Paired With Intensive Speech Therapy Promotes Reading Recovery in Chronic Aphasia

Not Applicable
Conditions
Aphasia
Language
First Posted Date
2016-06-14
Last Posted Date
2017-07-02
Lead Sponsor
Austin Speech Labs
Target Recruit Count
20
Registration Number
NCT02799017
Locations
🇺🇸

Austin Speech Labs, Austin, Texas, United States

News

No news found
© Copyright 2025. All Rights Reserved by MedPath